申请人:Takeda Chemical Industries, Ltd.
公开号:US05716944A1
公开(公告)日:1998-02-10
The present invention relates to a compound of the general formula (I): ##STR1## wherein ring A is a benzene ring that may be substituted; Y is a divalent group as a constituent member of ring B forming a 5- to 8-membered ring; Q.sub.1 is a group of the formula --X--P(O)(OR.sup.1)(OR.sup.2) wherein X is a bond or a divalent group; R.sup.1 and R.sup.2, identical or different, are hydrogen or a lower alkyl, or may be combined together to form a ring; Q.sub.2 is hydrogen, a hydrocarbon group that may be substituted or a heterocyclic group that may be substituted; and the group of the formula --CON(Q.sub.1)(Q.sub.2) is connected to the a- or b-position carbon atom, or a salt thereof, which is useful as prophylactic and therapeutic agents of various metabolic bone diseases such as osteoporosis.
本发明涉及一种通式(I)的化合物:##STR1## 其中环A是可能被取代的苯环;Y是形成5-至8-成员环的环B的组分成员的二价基团;Q.sub.1是式--X--P(O)(OR.sup.1)(OR.sup.2)的基团,其中X是键或二价基团;R.sup.1和R.sup.2,相同或不同,是氢或较低的烷基,或可以结合在一起形成环;Q.sub.2是氢、可能被取代的碳氢基团或可能被取代的杂环基团;以及式--CON(Q.sub.1)(Q.sub.2)的基团连接到α-或β-位碳原子,或其盐,其用作预防和治疗各种代谢性骨疾病,例如骨质疏松症的药物。